Enzo Biochem Inc (NYSE:ENZ)

6.69
Delayed Data
As of 4:02pm ET
 +0.22 / +3.40%
Today’s Change
5.35
Today|||52-Week Range
12.04
-17.91%
Year-to-Date
No recent news for Enzo Biochem Inc.

Today’s Trading

Previous close6.47
Today’s open6.46
Day’s range6.44 - 6.72
Volume125,066
Average volume (3 months)181,446
Market cap$302.7M
Data as of 4:02pm ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)-105.15%
Earnings growth (this year)-80.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+4.90%
P/E ratioNM
Price/Sales4.66
Price/Book3.37

Competitors

 Today’s
change
Today’s
% change
RDNTRadNet Inc-0.15-1.16%
NVTAInvitae Corp+0.26+3.49%
NTRANatera Inc-0.22-1.89%
NEONeogenomics Inc-0.14-1.22%
Data as of 4:02pm ET, 05/23/2018

Financials

Next reporting dateJune 11, 2018
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$107.8M
Annual profit (last year)-$2.5M
Net profit margin-2.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Secretary
Elazar Rabbani
President, CFO, Treasurer &
Director
Barry W. Weiner
Corporate headquarters
New York, New York

Forecasts